CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 (Q77220551)
Jump to navigation
Jump to search
scientific article published on 01 December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 |
scientific article published on 01 December 2001 |
Statements
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 (English)
M Lazzari
V Facchinetti
S Bernasconi
G Borleri
T Barbui